IRWD Company Profile and Key Details

Q: Who are the executives of IRWD?

Ms. Julie H. McHughExecutive ChairmanMr. Marcel MoulaisonVice President of Technical OperationsMr. Jason RickardSenior Vice President & Chief Operating OfficerDr. Michael Shetzline M.D., Ph.D.Chief Medical Officer, Senior Vice President and Head of Research & Drug Devel.Mr. Thomas A. McCourtChief Executive Officer & DirectorMr. Mike NanfitoVice President of Sales & Sales ExcellenceMr. Ronald SilverCorporation Controller & Principal Accounting OfficerMs. Beth CalitriHead of Corporation Communications & Media RelationsMr. John MinardoSenior Vice President, Chief Legal Officer & Sec.Greg MartiniVice President of Strategic Fin. & Investor RelationsMr. Sravan Kumar EmanySenior Vice President, Principal Financial Officer & Chief Financial Officer

NASDAQ : IRWD

Ironwood Pharmaceuticals

$4.47

-0.2-4.28%

At Close 4:00 PM

68.25

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Ironwood Pharmaceuticals, Inc. (IRWD) stock declined over -4.28%, trading at $4.47 on NASDAQ, down from the previous close of $4.67. The stock opened at $4.62, fluctuating between $4.37 and $4.65 in the recent session.

Stock Snapshot

4.67

Prev. Close

735.82M

Market Cap

4.37

Day Low

7.33

P/E Ratio

0.61

EPS (TTM)

1.17

Cash Flow per Share

4.62

Open

164.61M

Number of Shares

4.65

Day High

96.26%

Free Float in %

-2.22

Book Value

2.76M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 10, 2026	4.62	4.65	4.37	4.47	2.77M
Jul 09, 2026	4.69	4.78	4.55	4.67	3.14M
Jul 08, 2026	4.68	4.88	4.59	4.77	4.98M
Jul 07, 2026	4.48	4.67	4.41	4.47	3.39M
Jul 06, 2026	4.33	4.47	4.27	4.38	2.99M
Jul 02, 2026	4.17	4.39	4.16	4.33	2.65M
Jul 01, 2026	4.14	4.29	4.06	4.12	1.65M
Jun 30, 2026	4.25	4.32	4.12	4.21	2.58M
Jun 29, 2026	4.08	4.36	3.99	4.30	3.5M
Jun 26, 2026	3.79	4.17	3.79	4.13	7.1M
Jun 25, 2026	3.95	3.98	3.80	3.84	1.66M
Jun 24, 2026	3.80	4.01	3.80	3.91	1.76M
Jun 23, 2026	3.77	3.92	3.76	3.86	1.44M
Jun 22, 2026	3.60	3.91	3.57	3.82	2.52M
Jun 18, 2026	3.59	3.65	3.49	3.54	4.93M
Jun 17, 2026	3.66	3.72	3.51	3.52	1.63M
Jun 16, 2026	3.75	3.79	3.66	3.66	1.82M
Jun 15, 2026	3.77	3.77	3.64	3.69	2M
Jun 12, 2026	3.65	3.70	3.58	3.65	1.87M
Jun 11, 2026	3.37	3.78	3.33	3.63	2.78M

Contact Details

Boston, MA 02110

United States

https://www.ironwoodpharma.com 617 621 7722

About Company

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.

Stock Peers

ITCI

Intra-Cellular Therapies, Inc.$131.87 LNTH

-0.35-0.33%

Lantheus Holdings, Inc.$105.64 ANIP

-1.71-2.04%

ANI Pharmaceuticals, Inc.$82.07 SUPN

-0.29-0.59%

Supernus Pharmaceuticals, Inc.$48.46 HROW

-0.45-1.05%

Harrow Health, Inc.$42.48 INDV

-0.8-1.94%

Indivior Pharmaceuticals Inc$40.50 ETON

-0.72-1.93%

Eton Pharmaceuticals, Inc.$36.61 COLL

-0.58-1.62%

Collegium Pharmaceutical, Inc.$35.23 PAHC

-0.31-0.96%

Phibro Animal Health Corporation$32.07 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98

Frequently Asked Questions

What is the current Ironwood Pharmaceuticals, Inc. (IRWD) stock price?

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) stock price is $4.47 in the last trading session. During the trading session, IRWD stock reached the peak price of $4.65 while $4.37 was the lowest point it dropped to. The percentage change in IRWD stock occurred in the recent session was -4.28% while the dollar amount for the price change in IRWD stock was - $0.20.

IRWD's industry and sector of operation?

The NASDAQ listed IRWD is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Ironwood Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IRWD?

Ms. Julie H. McHugh
Executive Chairman
Mr. Marcel Moulaison
Vice President of Technical Operations
Mr. Jason Rickard
Senior Vice President & Chief Operating Officer
Dr. Michael Shetzline M.D., Ph.D.
Chief Medical Officer, Senior Vice President and Head of Research & Drug Devel.
Mr. Thomas A. McCourt
Chief Executive Officer & Director
Mr. Mike Nanfito
Vice President of Sales & Sales Excellence
Mr. Ronald Silver
Corporation Controller & Principal Accounting Officer
Ms. Beth Calitri
Head of Corporation Communications & Media Relations
Mr. John Minardo
Senior Vice President, Chief Legal Officer & Sec.
Greg Martini
Vice President of Strategic Fin. & Investor Relations
Mr. Sravan Kumar Emany
Senior Vice President, Principal Financial Officer & Chief Financial Officer

How IRWD did perform over past 52-week?

IRWD's closing price is 567.16% higher than its 52-week low of $0.67 where as its distance from 52-week high of $5.78 is -22.66%.

How many employees does IRWD have?

Number of IRWD employees currently stands at 253.

Link for IRWD official website?

Official Website of IRWD is: https://www.ironwoodpharma.com

How do I contact IRWD?

IRWD could be contacted at phone 617 621 7722 and can also be accessed through its website. IRWD operates from 100 Summer Street, Boston, MA 02110, United States.

How many shares of IRWD are traded daily?

IRWD stock volume for the day was 2.76M shares. The average number of IRWD shares traded daily for last 3 months was 2.48M.

What is the market cap of IRWD currently?

The market value of IRWD currently stands at $735.82M with its latest stock price at $4.47 and 164.61M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	253
Beta	0.21
Sales or Revenue	$442.74M
5Y Sales Change%	0.254%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Employees	253
Beta	0.21
Sales or Revenue	$442.74M
5Y Sales Change%	0.254%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

IRWD Company Profile and Key Details

Ironwood Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Shareholding & Insider Activity

Valuation Metrics

Price Forecast & Outlook

Key Takeaways